Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad
Eye on the Cure
Dr. Saad discusses an emerging therapy for Stargardt disease that has performed well in clinical trials.
August 9, 2024. Leonide Saad, PhD, founder and chief scientific officer of the biotech Alkeus, talks to host Ben Shaberman about his company’s emerging therapy, gildeuretinol, a modified form of vitamin A which has performed well in clinical trials for people with Stargardt disease.
This episode of the Eye on the Cure Podcast is sponsored by Alkeus Pharmaceuticals.
